Literature DB >> 20447554

Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer.

Yusuf Menda1, Laura L Boles Ponto, Kenneth J Dornfeld, Timothy J Tewson, G Leonard Watkins, Anjali K Gupta, Carryn Anderson, Sarah McGuire, Michael K Schultz, John J Sunderland, Michael M Graham, John M Buatti.   

Abstract

INTRODUCTION: The kinetics of the bone marrow uptake of 3'-deoxy-3'-[(18)F]fluorothymidine (FLT) before and early after initiation of chemoradiation therapy was investigated in patients with head and neck cancer.
METHODS: Fourteen subjects with head and neck cancer underwent FLT positron emission tomography (PET) at baseline and after 10 Gy of radiation therapy. Thirteen subjects also received one cycle of platinum-based chemotherapy before the second FLT PET. Kinetic parameters, including the flux constant based on compartmental analysis (K(FLT)) and the Patlak constant (K(Patlak)) for cervical marrow, were calculated. Standardized uptake values (SUVs) for the cervical marrow (inside the radiation field) and lumbar spine marrow (outside the radiation field) were also determined.
RESULTS: There was a significant drop in FLT uptake in the bone marrow inside the radiation field. Mean pretreatment uptake values for the cervical spine were SUV=3.08+/-0.66, K(FLT)=0.045+/-0.016 min(-1) and K(Patlak)=0.039+/-0.013 min(-1). After treatment, these values were SUV=0.74+/-0.19, K(FLT)=0.011+/-0.005 min(-1) and K(Patlak)=0.005+/-0.002 min(-1). Compartmental analysis revealed a significant drop in k(3) in irradiated cervical marrow. FLT uptake in the bone marrow outside the radiation field exhibited a significantly smaller decrease.
CONCLUSIONS: There is a marked decrease in FLT uptake in irradiated bone marrow after 10 Gy of radiation therapy to the head and neck. The drop in FLT uptake in irradiated marrow is due to a significant decrease in the net phosphorylation rate of FLT. (c( 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447554      PMCID: PMC2920567          DOI: 10.1016/j.nucmedbio.2010.02.005

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  20 in total

1.  Bone marrow regeneration and extension after extended field irradiation in Hodgkin's disease.

Authors:  P Rubin; S Landman; E Mayer; B Keller; S Ciccio
Journal:  Cancer       Date:  1973-09       Impact factor: 6.860

Review 2.  Radiation biology and cell population kinetics.

Authors:  L F Lamerton
Journal:  Phys Med Biol       Date:  1968-01       Impact factor: 3.609

3.  A study of erythropoiesis in the rat.

Authors:  R G Tarbutt
Journal:  Exp Cell Res       Date:  1967-11       Impact factor: 3.905

4.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

5.  Regeneration of locally irradiated bone marrow. I. Dose dependent, long-term changes in the rat, with particular emphasis upon vascular and stromal reaction.

Authors:  W H Knospe; J Blom; W H Crosby
Journal:  Blood       Date:  1966-09       Impact factor: 22.113

6.  Effect of focal irradiation on human bone marrow.

Authors:  T J Lehar; J M Kiely; G L Pease; P W Scanlon
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1966-01

7.  Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies.

Authors:  T Higashi; S J Fisher; R S Brown; K Nakada; G L Walter; R L Wahl
Journal:  J Nucl Med       Date:  2000-12       Impact factor: 10.057

8.  Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

Authors:  Aren van Waarde; David C P Cobben; Albert J H Suurmeijer; Bram Maas; Willem Vaalburg; Erik F J de Vries; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

9.  Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Authors:  Sarah Everitt; Rodney J Hicks; David Ball; Tomas Kron; Michal Schneider-Kolsky; Tania Walter; David Binns; Michael Mac Manus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-20       Impact factor: 7.038

10.  Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

Authors:  Janet S Rasey; John R Grierson; Linda W Wiens; Pamella D Kolb; Jeffrey L Schwartz
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057

View more
  8 in total

Review 1.  Image-based biomarkers in clinical practice.

Authors:  John E Bayouth; Thomas L Casavant; Michael M Graham; Milan Sonka; Manickam Muruganandham; John M Buatti
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

2.  The vertebral 3'-deoxy-3'-18F-fluorothymidine uptake predicts the hematological toxicity after systemic chemotherapy in patients with lung cancer.

Authors:  Yukihiro Umeda; Tetsuya Tsujikawa; Masaki Anzai; Miwa Morikawa; Yuko Waseda; Maiko Kadowaki; Hiroko Shigemi; Shingo Ameshima; Tetsuya Mori; Yasushi Kiyono; Hidehiko Okazawa; Tamotsu Ishizuka
Journal:  Eur Radiol       Date:  2019-04-10       Impact factor: 5.315

3.  3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.

Authors:  Sarah M McGuire; Yusuf Menda; Laura L Boles Ponto; Brandie Gross; John Buatti; John E Bayouth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-06       Impact factor: 7.038

4.  Pharmacoimaging of Blood-Brain Barrier Permeable (FDG) and Impermeable (FLT) Substrates After Intranasal (IN) Administration.

Authors:  Laura L Boles Ponto; Susan Walsh; Jiangeng Huang; Christine Mundt; Katherine Thede-Reynolds; G Leonard Watkins; John Sunderland; Michael Acevedo; Maureen Donovan
Journal:  AAPS J       Date:  2017-12-07       Impact factor: 4.009

5.  Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer.

Authors:  Virginie Frings; Adrianus J de Langen; Maqsood Yaqub; Robert C Schuit; Astrid A M van der Veldt; Otto S Hoekstra; Egbert F Smit; Ronald Boellaard
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

6.  Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.

Authors:  Sarah M McGuire; Sudershan K Bhatia; Wenqing Sun; Geraldine M Jacobson; Yusuf Menda; Laura L Ponto; Brian J Smith; Brandie A Gross; John E Bayouth; John J Sunderland; Michael M Graham; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-19       Impact factor: 7.038

7.  Spatial mapping of functional pelvic bone marrow using FLT PET.

Authors:  Sarah M McGuire; Yusuf Menda; Laura L Boles Ponto; Brandie Gross; Mindi TenNapel; Brian J Smith; John E Bayouth
Journal:  J Appl Clin Med Phys       Date:  2014-07-08       Impact factor: 2.102

8.  Relative skeletal distribution of proliferating marrow in the adult dog determined using 3'-deoxy-3'-[18 F]fluorothymidine.

Authors:  Joshua A Rowe; Federica Morandi; Dustin R Osborne; Jonathan S Wall; Stephen J Kennel; Robert B Reed; Amy K LeBlanc
Journal:  Anat Histol Embryol       Date:  2018-10-23       Impact factor: 1.114

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.